BSE Fundamental Analysis - Balance Sheet & Share Holding Pattern

EMMESSARBIOTECHNUTRITION01 Jan 1900

₹

0.00 (0.00%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in

EMMESSARBIOTECHNUTRITION01 Jan 1900

₹

0.00 (0.00%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date
27-Feb-2024	BC	EMMESSAR BIOTECH & NUTRITION LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/03/2024 inter alia to consider and approve inducting / appointing an Ind	20-Mar-2024
20-Mar-2024	BC	Pursuant to Reg 30, LODR, Reg 2015, Mr. Dinesh Kumar Deora is appointed as Additional Independent Director w.e.f. 20.03.2024	20-Mar-2024
23-Jan-2024	BC	EMMESSAR BIOTECH & NUTRITION LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/02/2024 inter alia to consider and approve Pursuant to Regulation 29 and	03-Feb-2024
27-Nov-2023	BC	EMMESSAR BIOTECH & NUTRITION LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/12/2023 inter alia to consider and approve Pursuant to Reg. 29 & 33 of S	09-Dec-2023
27-Oct-2023	BC	The Board of Directors held the additional Board Meeting to appoint an additional director and to fix the date of EGM for voting the resolution which was missed during the AGM. There may be delay	24-Nov-2023

No Rights has been declared by EMMESSARBIOTECHNUTRITION

Book Closure

Record Date	Split Date	Purpose
20-Mar-2024	-	EMMESSAR BIOTECH & NUTRITION LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/03/2024 inter alia to consider and approve inducting / appointing an Ind
20-Mar-2024	-	Pursuant to Reg 30, LODR, Reg 2015, Mr. Dinesh Kumar Deora is appointed as Additional Independent Director w.e.f. 20.03.2024
03-Feb-2024	-	EMMESSAR BIOTECH & NUTRITION LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/02/2024 inter alia to consider and approve Pursuant to Regulation 29 and
09-Dec-2023	-	EMMESSAR BIOTECH & NUTRITION LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/12/2023 inter alia to consider and approve Pursuant to Reg. 29 & 33 of S
24-Nov-2023	-	The Board of Directors held the additional Board Meeting to appoint an additional director and to fix the date of EGM for voting the resolution which was missed during the AGM. There may be delay

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Jubilant Industries Ltd ₹1,139.50(-3.75/-0.33%)	1,139.50	-3.75	1,716.90	172.01	0.00	5.58
Linde India Ltd ₹8,392.65(+111.65/1.35%)	8,392.65	+111.65	71,572.52	105.60	170.01	22.24
Gujarat Alkalies & Chemicals Ltd ₹784.10(-9.25/-1.17%)	784.10	-9.25	5,758.43	15.56	0.00	0.92
Bodal Chemicals Ltd ₹76.05(-1.05/-1.36%)	76.05	-1.05	956.63	8.90	194.95	0.85
Omkar Speciality Chemicals Ltd ₹6.90(-0.20/-2.82%)	6.90	-0.20	14.20	-8.39	0.00	-0.08

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	0.33	0.08	0.07	0.32	0.43	0.07
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	0.33	0.08	0.07	0.32	0.43	0.07
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	0.53	0.53	0.46	0.42	0.44	0.43
Total Income	0.85	0.61	0.52	0.73	0.87	0.50
Total Expenditure	0.53	0.30	0.34	0.47	0.60	0.27
PBIDT	0.32	0.31	0.18	0.26	0.27	0.23
Interest	0.00	0.00	0.00	0.00	0.00	0.00
PBDT	0.32	0.31	0.18	0.26	0.27	0.23
Depreciation	0.02	0.02	0.02	0.02	0.02	0.02
Tax	0.09	0.08	0.05	0.05	0.10	0.10
Deferred Tax	0.08	0.01	0.06	0.00	0.17	-0.03
Reported Profit After Tax	0.13	0.20	0.05	0.20	-0.02	0.13
Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	0.13	0.20	0.05	0.20	-0.02	0.13

EPS (Unit Curr.)	0.26	0.39	0.11	0.38	-0.04	0.27
EPS (Adj) (Unit Curr.)	0.26	0.39	0.11	0.38	-0.04	0.27
Calculated EPS (Unit Curr.)	0.26	0.39	0.11	0.39	-0.04	0.27
Calculated EPS (Adj) (Unit Curr.)	0.26	0.39	0.11	0.39	-0.04	0.27
Calculated EPS (Ann.) (Unit Curr.)	1.03	1.58	0.44	1.58	-0.18	1.08
Calculated EPS (Adj) (Ann.) (Unit Curr.)	1.03	1.58	0.44	1.58	-0.18	1.08
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	5.00	5.00	5.00	5.00	5.00	5.00
Reserve & Surplus	0.00	0.00	0.00	0.00	0.00	0.00
Face Value	10.00	10.00	10.00	10.00	10.00	10.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	96.97	387.50	257.14	81.25	62.79	328.57
PBDTM(%)	96.97	387.50	257.14	81.25	62.79	328.57
PATM(%)	39.39	250.00	71.43	62.50	-4.65	185.71

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	5.00	5.00	5.00	5.00	5.00	5.00
Reserves Total	1.67	1.17	0.70	-0.73	-1.49	-2.01
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	6.67	6.17	5.70	4.27	3.51	2.99
Secured Loans	0.08	0.00	0.00	0.00	0.07	0.00
Unsecured Loans	0.00	0.00	0.00	0.00	0.00	0.00
Total Debt	0.08	0.00	0.00	0.00	0.07	0.00
Total Liabilities	6.75	6.17	5.70	4.27	3.58	2.99
APPLICATION OF FUNDS :
Gross Block	2.93	2.91	2.60	2.60	2.63	2.88
Less : Accumulated Depreciation	0.93	0.83	0.74	0.68	0.64	0.63
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	2.00	2.08	1.86	1.92	1.99	2.25
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	0.00	0.00	0.00	0.00	0.00	0.00
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.01	0.01	0.01	0.01	0.01	0.01
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	0.14	0.07	0.07	1.15	0.73	0.09
Sundry Debtors	0.01	0.01	2.71	0.03	0.04	0.03
Cash and Bank	5.19	4.58	2.47	1.88	0.71	0.27
Loans and Advances	0.59	0.19	0.14	0.20	0.91	0.68
Total Current Assets	5.93	4.85	5.39	3.26	2.40	1.07
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	0.11	0.13	0.98	1.02	0.76	0.14
Provisions	0.23	0.21	0.42	0.08	0.07	0.06
Total Current Liabilities	0.34	0.33	1.41	1.10	0.83	0.19
Net Current Assets	5.59	4.52	3.99	2.16	1.57	0.88
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	0.15	0.34	0.57	0.95	0.76	0.46
Deferred Tax Liability	0.28	0.06	0.03	0.01	0.00	0.00
Net Deferred Tax	-0.13	0.28	0.54	0.94	0.76	0.46
Total Assets	7.47	6.88	6.40	5.02	4.33	3.60
Contingent Liabilities	0.00	0.00	0.00	0.00	0.00	0.00

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Cash and Cash Equivalents at Beginning of the year	0.18	0.53	0.05	0.08	0.06
Net Cash from Operating Activities	0.38	2.27	0.47	1.03	0.39
Net Cash Used In Investing Activities	-0.55	-2.61	0.01	-1.06	-0.37
Net Cash Used In Financing Activities	0.00	0.00	0.00	0.00	0.00
Net Inc./Dec In Cash And Cash Equivalents	-0.17	-0.34	0.48	-0.03	0.01
Cash And Cash Equivalents At End Of The Year	0.01	0.18	0.53	0.05	0.08

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

59.53%

FII Shareholding

0.00%

DII Shareholding

0.20%

Public Shareholding

40.28%

**Promoter pledged shareholding 59.53%

About Emmessar Biotech & Nutrition Ltd

Emmessar Biotech & Nutrition Ltd is in the Chemicals sector, having a market capitalization of Rs. 19.93 crores. It has reported a sales of Rs. 0.33 crores and a net profit of Rs. 0.13 crores for the quarter ended December 2018. The company management includes MSR Ayyangar, MSR Ayyangar,Anuradha Raghavan,Sarada Raghavan,Anantharama Sethmani Subramanian,Jayavel Balaiah Nadar,Rajalakshmi Srinivasa Raghavan,Priyanka Omprakash Sharma,Milind S Desai (Emmessar Biotech & Nutrition Ltd) among others.

Chairman

MSR Ayyangar

Registered office

Plot No T-3/2 MIDC Area,P O Box No 39 Taloja,Raigad,Maharashtra,410208

FAX :

Background

Incorporation Year1992

Face Value₹10

Market Lot1

How to buy shares on nse?

To buy shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the share price today?

The shares price on nse is Rs.0 today.

What is the market cap of shares on ?

The company has a market capitalization of Rs.0.00Cr

What is the PE & PB ratio of shares ?

PE is 0 and PB is 0

What is the 52 Week High and Low of shares?

stock price high: Rs.0 stock price low: Rs.0